Uptake, transport, and delivery of antimicrobial agents by human polymorphonuclear neutrophils
about
Immunomodulating effects of antibiotics used in the prophylaxis of bacterial infections in advanced cirrhosisImportance of relating efficacy measures to unbound drug concentrations for anti-infective agentsCiprofloxacin modulates cytokine/chemokine profile in serum, improves bone marrow repopulation, and limits apoptosis and autophagy in ileum after whole body ionizing irradiation combined with skin-wound traumaUptake, transport, delivery, and intracellular activity of antimicrobial agents.Effect of ciprofloxacin on killing of Actinobacillus actinomycetemcomitans by polymorphonuclear leukocytes.Recent advances in our understanding of Streptococcus pneumoniae infection.Influence of P-glycoprotein inhibitors on accumulation of macrolides in J774 murine macrophages.Moxifloxacin in the treatment of skin and skin structure infections.Ciprofloxacin transport by chemoattractant-activated polymorphonuclear leukocytes: regulation by priming and protein kinase CPharmacokinetics of tulathromycin in healthy and neutropenic mice challenged intranasally with lipopolysaccharide from Escherichia coliMurine models of pneumococcal pneumonia and their applicability to the study of tissue-directed antimicrobials.Infection site concentrations: their therapeutic importance and the macrolide and macrolide-like class of antibiotics.Fosfomycin enhances phagocyte-mediated killing of Staphylococcus aureus by extracellular traps and reactive oxygen species.Azithromycin kills invasive Aggregatibacter actinomycetemcomitans in gingival epithelial cells.Clinical applications of azithromycin microspheres in respiratory tract infectionsAntibacterial and immunomodulatory properties of azithromycin treatment implications for periodontitis.Understanding the pharmacokinetics of tulathromycin: a pulmonary perspective.Distribution characteristics of clarithromycin and azithromycin, macrolide antimicrobial agents used for treatment of respiratory infections, in lung epithelial lining fluid and alveolar macrophages.Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycinStandard PK/PD concepts can be applied to determine a dosage regimen for a macrolide: the case of tulathromycin in the calf.Moxifloxacin and azithromycin but not amoxicillin protect human respiratory epithelial cells against streptococcus pneumoniae in vitro when administered up to 6 hours after challenge.Single-dose azithromycin for acute otitis media: a pharmacokinetic/pharmacodynamic rationale.Toll-like receptor-4 mediates cigarette smoke-induced cytokine production by human macrophages.Pulmonary pharmacokinetics of tulathromycin in swine. Part I: Lung homogenate in healthy pigs and pigs challenged intratracheally with lipopolysaccharide of Escherichia coli.Pulmonary pharmacokinetics of tulathromycin in swine. Part 2: Intra-airways compartments.Ubiquitous Nature of Fluoroquinolones: The Oscillation between Antibacterial and Anticancer Activities.Relative effectiveness of azithromycin in killing intracellular Porphyromonas gingivalis.
P2860
Q26778064-0993A153-7BED-4ACB-9D5C-BF43482A2AC9Q26827380-844AE807-F8E7-4043-933E-633AF3445541Q28487821-F678F38E-1F9C-4CCA-875F-F1AD24A1D1BAQ30438771-3A102785-1EFE-4810-9086-2BF017243BD3Q34108571-7B251325-41C7-4945-82BB-FA7DB2B49D1AQ34201900-AEB99F4E-811C-4C71-A9FC-E7BC71A61722Q34734399-49B5EEAA-4A59-40ED-AA97-B222B0753519Q35919259-B9576BBC-7BD5-4666-943D-BFA763E1BEC3Q36047088-69EAB172-A286-4569-98BC-73687A1A937CQ36171670-D09A405B-BDB9-489F-993E-D9C735C11DA1Q36320604-F893BF3B-FC3D-4357-A765-D7C7227DC7C3Q36320613-701A63FC-B070-4916-A26D-F75D6C491017Q36499980-AA96D610-7E14-4FDD-B909-A9248B9D30C1Q36667115-F0EA4394-1909-481E-A356-9A441460CA30Q37059889-F74C5AE5-BB9D-4F66-8041-67B991026DD8Q38085248-30F41C71-0339-4A42-9481-A7EC92C3DC48Q38151858-21F73487-153C-4386-A32B-33023ABD7C7FQ39496039-85AB0276-BCF3-4BFC-8305-5EC6339B0F47Q40417004-9C9C2B8B-327B-48DD-B753-FE2B624597CBQ40584376-2033E7E5-C455-407B-82E6-F1FD143725C3Q40667360-5EB56475-CC90-49A7-AD01-8D72EF321A17Q40840103-4418FF48-7D51-4ABD-A10C-B7F6AAF62588Q42402869-6DE7AE02-1504-40E5-81B3-43B584934C82Q43917247-95E899FB-030A-401E-85DC-12DE373FEB90Q46490969-35F9DBD3-7DCE-4EEE-B02B-3C368519EEEAQ47101582-57F02C27-3DD9-460A-99A6-66CF8F83D65CQ54671302-C1F3269E-4C81-4B77-8C7C-D7AAFBF73159
P2860
Uptake, transport, and delivery of antimicrobial agents by human polymorphonuclear neutrophils
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Uptake, transport, and deliver ...... polymorphonuclear neutrophils
@ast
Uptake, transport, and deliver ...... polymorphonuclear neutrophils
@en
type
label
Uptake, transport, and deliver ...... polymorphonuclear neutrophils
@ast
Uptake, transport, and deliver ...... polymorphonuclear neutrophils
@en
prefLabel
Uptake, transport, and deliver ...... polymorphonuclear neutrophils
@ast
Uptake, transport, and deliver ...... polymorphonuclear neutrophils
@en
P2860
P1476
Uptake, transport, and deliver ...... polymorphonuclear neutrophils
@en
P2093
G L Mandell
P2860
P304
P356
10.1128/AAC.45.6.1794-1798.2001
P407
P577
2001-06-01T00:00:00Z